CIK 0001285819 · Non-accelerated filer<br>Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 911663741
- Phone
- 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,114,339
- in 5 filings, $626K under 10b5-1 plans
Net −$2,114,339. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-12 | Schocken Joseph L Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2026-07-22 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award · Stock Option (right to buy) | +1,000,000 | 1,000,000 | ||
| 2026-07-22 | Cancelmo Peter B VP, General Counsel | Grant or award · Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2026-07-22 | Borges David J. VP, Finance & CAO | Grant or award · Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2026-06-18 | Shah Rajiv Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-06-18 | Perkinson Diana T. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-06-18 | Hood Leroy E. MD PhD Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-06-18 | HANISH ARNOLD C Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-06-18 | Demopulos Peter A MD Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-06-18 | Cable Thomas J. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-06-18 | Bumol Thomas F. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-05-22 | Cable Thomas J. Director | Option exercise 10b5-1 | +7,500 | $10.84 | $81K | 42,567 |
| 2026-05-22 | Cable Thomas J. Director | Sale 10b5-1 | −7,500 | $11.61 | $87K | 35,067 |
| 2026-05-22 | Cable Thomas J. Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 0 | ||
| 2026-02-18 | Demopulos Gregory A MD Chairman, CEO & President | Option exercise | +400,000 | $10.27 | $4.1M | 1,826,986 |
| 2026-02-18 | Demopulos Gregory A MD Chairman, CEO & President | Shares withheld for taxes | −357,678 | $11.93 | $4.3M | 1,469,308 |
| 2026-02-18 | Demopulos Gregory A MD Chairman, CEO & President | Option exercise · Stock option (right to buy) | −400,000 | 0 | ||
| 2026-01-13 | Borges David J. VP, Finance & CAO | Option exercise | +30,000 | $3.06 | $92K | 30,000 |
| 2026-01-13 | Borges David J. VP, Finance & CAO | Sale | −30,000 | $12.31 | $369K | 0 |
| 2026-01-13 | Borges David J. VP, Finance & CAO | Option exercise · Stock Option (right to buy) | −30,000 | 65,000 |
Page 3 of 9 · 178 trades